...
首页> 外文期刊>CNS neuroscience & therapeutics. >Histamine H3 Receptor Antagonist Prevents Memory Deficits and Synaptic Plasticity Disruption Following Isoflurane Exposure
【24h】

Histamine H3 Receptor Antagonist Prevents Memory Deficits and Synaptic Plasticity Disruption Following Isoflurane Exposure

机译:组胺H3受体拮抗剂可防止异氟烷暴露后的记忆缺陷和突触可塑性破坏。

获取原文
           

摘要

Summary BackgroundExposure to pharmacological concentration of inhaled anesthetics such as isoflurane can cause short- or long-term cognitive impairments in preclinical studies. The selective antagonists of the histamine H3 receptors are considered as a promising group of novel therapeutic agents for the treatment of cognitive disorders. In this study, we investigated whether ciproxifan, a nonimidazole antagonist of H3 histamine receptors, could overcome the functional and electrophysiological sequela associated with isoflurane anesthesia. MethodsAdult male Sprague Dawley rats were exposed to 1.4% isoflurane or vehicle gas for 2 h. The memory tests (novel object recognition and passive avoidance) as well as in vivo hippocampal excitatory synaptic potentials were recorded 24 h postanesthesia. Locomotor activity, anxiety, and nociception 24 h after isoflurane were also examined. The drugs (ciproxifan 3 mg/kg or saline) were intraperitoneally injected 30 min prior to the behavioral tests or long-term potentiation induction. ResultsAnimals that were previously (24 h) exposed to 1.4% isoflurane for 2 h displayed no preference for novel objects and had impaired retention of a passive avoidance response at 1 h after sample phase. Treating isoflurane-exposed rats with ciproxifan significantly improved the memory performance, as evidenced by an increased discrimination ratio in objects recognition and prolonged retention time in passive avoidance test. Accordingly, hippocampus long-term potentiation was reduced in animals that received isoflurane, while administration of ciproxifan completely abolished the effect of isoflurane exposure on synaptic plasticity. Neither isoflurane nor ciproxifan altered motor performance, anxiety, and nociceptive responses. ConclusionThese results suggest that H3R in the CNS, probably in the hippocampus, may serve as therapeutic target for improvement of anesthesia-associated cognitive deficits.
机译:发明背景在临床前研究中,吸入麻醉药(例如异氟烷)的药理浓度暴露可能会导致短期或长期的认知障碍。组胺H3受体的选择性拮抗剂被认为是用于治疗认知障碍的有希望的新型治疗剂。在这项研究中,我们研究了H3组胺受体的非咪唑拮抗剂ciproxifan是否可以克服与异氟烷麻醉有关的功能和电生理后遗症。方法成年雄性Sprague Dawley大鼠暴露于1.4%异氟烷或载气中2小时。麻醉后24小时记录记忆测试(新物体识别和被动回避)以及体内海马兴奋性突触电位。还检查了异氟烷24小时后的自发活动,焦虑和伤害感受。在行为测试或长期增强诱导之前30分钟腹膜内注射药物(西吡昔芬3 mg / kg或盐水)。结果先前(24小时)暴露于1.4%异氟烷2小时的动物对新物体没有偏爱,并且在样品阶段1小时后被动回避反应的保持力受损。用ciproxifan处理暴露于异氟烷的大鼠,可显着改善记忆性能,这可通过增加物体识别的辨别率和延长被动回避测试的保留时间来证明。因此,接受异氟烷的动物海马的长期增强能力降低,而给予环丙硫磷则完全消除了异氟烷暴露对突触可塑性的影响。异氟烷和西普西芬均不能改变运动功能,焦虑和伤害反应。结论这些结果表明中枢神经系统中的H3R可能是改善与麻醉有关的认知缺陷的治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号